North America Cancer Hormone Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Cancer Hormone Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Cancer Hormone Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Cancer Hormone Therapy Market Regional Analysis

6.2 North America Cancer Hormone Therapy Market Revenue 2021-2031 (US$ Million)

6.3 North America Cancer Hormone Therapy Market Forecast Analysis

7. North America Cancer Hormone Therapy Market Analysis – by Drug Class

7.1 GnRH Analogs

7.1.1 Overview
7.1.2 GnRH Analogs: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 GnRH Antagonists

7.2.1 Overview
7.2.2 GnRH Antagonists: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Androgen Receptor Antagonists

7.3.1 Overview
7.3.2 Androgen Receptor Antagonists: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Aromatase Inhibitors

7.4.1 Overview
7.4.2 Aromatase Inhibitors: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Selective Estrogen Receptor Modulators

7.5.1 Overview
7.5.2 Selective Estrogen Receptor Modulators: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Estrogen Receptor Antagonists

7.6.1 Overview
7.6.2 Estrogen Receptor Antagonists: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Thyroid Hormone Therapy

7.7.1 Overview
7.7.2 Thyroid Hormone Therapy: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Other Drug Classes

7.8.1 Overview
7.8.2 Other Drug Classes: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Cancer Hormone Therapy Market Analysis – by Cancer Type

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Prostate Cancer

8.2.1 Overview
8.2.2 Prostate Cancer: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Endometrial Cancer

8.3.1 Overview
8.3.2 Endometrial Cancer: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Ovarian Cancer

8.4.1 Overview
8.4.2 Ovarian Cancer: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Thyroid Cancer

8.5.1 Overview
8.5.2 Thyroid Cancer: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Cancer Types

8.6.1 Overview
8.6.2 Other Cancer Types: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Cancer Hormone Therapy Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Implantable

9.3.1 Overview
9.3.2 Implantable: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Cancer Hormone Therapy Market Analysis – by Sales Channel

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Cancer Treatment Centers

10.2.1 Overview
10.2.2 Cancer Treatment Centers: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Specialty Clinics

10.3.1 Overview
10.3.2 Specialty Clinics: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Retail Pharmacies

10.4.1 Overview
10.4.2 Retail Pharmacies: North America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Cancer Hormone Therapy Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Cancer Hormone Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
11.2.1.1 North America Cancer Hormone Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 US: North America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.1.2 US: North America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.1.3 US: North America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.1.4 US: North America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.2 Canada: North America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Canada: North America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.2.2 Canada: North America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.2.3 Canada: North America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.2.4 Canada: North America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.3 Mexico: North America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Mexico: North America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.3.2 Mexico: North America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.3.3 Mexico: North America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.3.4 Mexico: North America Cancer Hormone Therapy Market Breakdown, by Sales Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 AbbVie

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Eli Lilly and Co

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Astellas Pharma Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Ipsen Pharma

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Cancer Hormone Therapy Market (2021–2031)